Company: TACOW
Filing Date: 2025-04-09
Form Type: S-1/A
Source: 0001829126-25-002484
Chunk: 181

Company: Berto Acquisition Corp.
Filing Date: 2025-04-09
Form: S-1/A
Chunk 181
---
 exercise of such warrants may result in material dilution
to our public shareholders. See the sections titled “Dilution” and “Risk Factors — The nominal purchase price paid by our sponsor, sponsor affiliates and a consultant for the founder shares and the anti-dilution adjustment we intend to make with respect to the founder shares if the size of this offering is increased may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination, and the value of the founder shares following completion of our initial business combination is likely to be substantially higher than the nominal price paid for them, even if the trading price of our ordinary shares at such time is substantially less than $10.00 per share.”

Our founder shares are of the
same class as the ordinary shares included in the units being sold in this offering. Our founder shares are identical to the public shares
except that the founder shares are entitled to registration rights and subject to certain transfer restrictions, as described in more
detail in this prospectus. Unlike in other SPACs, our founder shares do not have conversion and anti-dilution rights in connection with
the closing of a business combination. Therefore, if additional ordinary shares or equity-linked securities are issued or deemed issued
in connection with our initial business combination, our founder shares will be diluted by such issuance pro rata with the public shares.

Pursuant to a letter agreement
to be entered with us, each of our sponsor, officers and directors, and the consultant who owns founder shares has agreed to restrictions
on its ability to transfer, assign, or sell the founder shares and private placement warrants, as summarized in the table below. Our
letter agreement with our sponsor, officers and directors, and consultant, which contains the below provisions relating to transfer restrictions
of our founder shares and private placement warrants, may be amended without shareholder approval. Such transfer restrictions have been
amended in connection with business combinations for certain other SPACs. While we do not expect our board to approve any amendment to
the letter agreement prior to our initial business combination, it may be possible that our board, in exercising its business judgment
and subject to its fiduciary duties, chooses to approve one or more amendments to the letter agreement.

| Subject    
 Securities |     | Expiration                                                                                                                                
 Date                                                                                                                                      |     | Persons                 
 Subject to Restrictions |     | Exceptions                                                                                                                          
 to Transfer Restrictions                                                                                                            |
| Founder    
 Shares     |     | The                                                                                                                                       
 founder shares are not